Skip to main content
SB18-023

Promote Off-label Use Pharmaceutical Products

Type Bill
Session 2018 Regular Session
Subjects
Health Care & Health Insurance

Concerning the promotion of the off-label use of pharmaceutical products.

Bill Summary:

The bill allows a pharmaceutical manufacturer or its representative to promote the off-label use of a prescription drug, biological product, or device approved by the United States food and drug administration.


(Note: This summary applies to this bill as introduced.)

Status

Lost

Introduced

Lost

Related Documents & Information

Date Version Documents
01/10/2018 Introduced PDF
Date Version Documents
09/05/2018 FN2 PDF
01/19/2018 FN1 PDF
Activity Vote Documents
Postpone Senate Bill 18-023 indefinitely. The motion passed on a vote of 4-1. Vote summary
Date Location Action
02/15/2018 Senate Senate Committee on Health & Human Services Postpone Indefinitely
01/10/2018 Senate Introduced In Senate - Assigned to Health & Human Services

Prime Sponsor

Co-Sponsor